A monthly audio round-up detailing the contents of the latest issue of DTB.

Articles:
A risky business? DTB 2010; 48: 25
Using NSAIDs in cardiovascular disease DTB 2010; 48: 26 - 29
Managing primary hyperparathyroidism in primary care DTB 2010; 48: 30 - 33
Body surface area for adjustment of drug dose DTB 2010; 48: 33 - 36

A monthly audio round-up detailing the contents of the latest issue of DTB. Articles: A risky business? DTB 2010; 48: 25 Using NSAIDs in cardiovascular disease DTB 2010; 48: 26 - 29 Managing primary hyperparathyroidism in primary care DTB 2010; 48: 30 - 33 Body surface area for adjustment of drug dose DTB 2010; 48: 33 - 36

In this issue - March 2010

From June 2023, all our podcasts will move to https://dtbbmj.podbean.com.
You can continue with your subscription on your favourite podcast App.

For 50 years, Drug and Therapeutics Bulletin (DTB) has provided rigorous and independent evaluations of, and practical advice on, individual treatments and the overall management of disease for doctors, pharmacists and other healthcare professionals. DTB has always been wholly independent of the pharmaceutical industry, Government and regulatory authorities. DTB is also free of advertising and other forms of commercial sponsorship.
Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page - https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309.
* The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

Science

From June 2023, all our podcasts will move to https://dtbbmj.podbean.com. You can continue with your subscription on your favourite podcast App. For 50 years, Drug and Therapeutics Bulletin (DTB) has provided rigorous and independent evaluations of, and practical advice on, individual treatments and the overall management of disease for doctors, pharmacists and other healthcare professionals. DTB has always been wholly independent of the pharmaceutical industry, Government and regulatory authorities. DTB is also free of advertising and other forms of commercial sponsorship. Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page - https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

Share In this issue - March 2010

Sign up to save your podcasts

In this issue - March 2010

In this issue - March 2010